Minor variation for application TFDA-2024-0071. Minor variation: New Dosage Strength for Lorlatenilib — major revision

Variation Number
TFDA-2024-0071-V171
Type
Minor
Application
Status
Draft
Fee
€2,312
Submitted
—
Approved
—
Description

Minor variation: New Dosage Strength for Lorlatenilib — major revision